Cincinnati Children's Hospital Medical Center Logo

Hematology / Oncology

Loading...

Grants, Contracts, and Industry Agreements

Grant and Contract Awards Annual Direct / Project Period Direct

CRIPE, T

Oncolytic HSV Cancer Therapy in Immunocompetent Sarcoma Models
R01 CA 11400407/01/06 - 05/31/11 $172,353 / $887,500
Virotherapy for Neuroblastoma Stem Cells
R21 CA 13366308/01/08 - 07/31/10 $112,500 / $247,500
Cincinnati NF1 Preclinical Testing Center
06/01/08 - 05/31/11 $216,364 / $720,000
Cincinnati Center for Neurofibromatosis Research - Core B
P50 NS 05753109/15/08 - 06/30/13 $100,525 / $502,625
CTSA: Pilot and Collaborative Studies
UL1 RR 02631404/03/09 - 03/31/14 $24,238 / $24,238

DAVIES, S

Predictors of Adult Leukemia
R01 CA 10714304/01/05 - 03/31/10 $11,712 / $56,904
Antileukemic Effect of NK Cells in HCT for Pediatric AML
R01 CA 12058308/01/07 - 06/30/12 $8,686 / $43,580
Childhood Cancer Survivor Study
U54 CA 05572712/01/05 - 11/30/10 $50,000 / $643,729
Mechanisms of RET, PTC Rearrangements in Thyroid Center
R01 CA 08804103/01/09 - 02/28/10 $6,399 / $6,399
The Children's Oncology Group Chairs Grant
U10 CA 09854303/01/08 - 02/28/10 $11,956 / $23,619
HSCT-CHESS to Enhance Hematopoietic Transplant Recovery
R01 CA11919606/01/08 - 05/31/10 $24,330 / $34,330
HSCT-CHESS to Enhance Hematopoietic Transplant Recovery - Per Patient
R01 CA11919606/01/08 - 05/31/10 $6,801 / $12,000

DRISSI, R

Decreasing Side Effects of Radiation Therapy for Cancer Patients
06/01/09 - 05/31/10 $36,000 / $36,000

FILIPOVICH, L

Laboratory Diagnosis and Immunologic Characterization Conference Grant
R13 AI 08137911/01/08 - 10/31/09 $3,000 / $3,000
Hypoxia and Potassium Channel Activity in T Lymphocytes
R01 CA09528606/01/2009 - 04/30/2013 $19,190 / $80,284

FOULADI, M

Children's Oncology Group Phase I Consortium 17197
U01 CA 09745208/01/07 - 01/31/09 $11,267 / $32,000
The Pediatric Brain Tumor Consortium
U01 CA 08145704/01/08 - 03/31/10 $14,920 / $26,047
A Study of Radiotherapy and Concurrent Bevacizumab
01/01/09 - 12/31/09 $50,000 / $50,000
Study of Radiotherapy and Concurrent Bevacizumab
05/01/09 - 04/30/10 $25,000 / $25,000
Molecular Profiling of High-Grade Gilomas in Children
06/01/09 - 05/31/10 $36,000 / $36,000

GRUPPO, R

Hemophilia Prevention Network
U01 DD 00020310/01/97 - 09/29/09 $21,000 / $155,771
Molecular and Clinical Biology of VWD
P01 HL 08158806/01/09 - 06/30/09 $2,000 / $2,000
Hemophilia and Thrombosis Center
06/01/03 - 05/31/10 $58,200 / $297,658
Hemophilia Comprehensive Care and Prevention Core Center for Bleeding Disorders
5H30MC001510/01/97 - 05/31/10 $14,500 / $138,690

JOINER, C

Cincinnati Comprehensive Sickle Cell Center
U54 HL 07087106/15/08 - 03/31/12 $1,019,258 / $4,067,809
Mitchell, MProject 3108,644
Joiner, CProject 4302,751
Malik, PProject 5389,734
Joiner, CScholar105,000
Joiner, CAdmin Core103,681
Joiner, CClinical9,448
Cincinnati Sickle Cell Project
31-6-006-1-CC-0807/01/08 - 06/30/09 $117,363 / $117,368
Ohio Sickle Cell Alliance for Research
U10 HL 08372103/01/09 - 03/31/10 $86,114 / $172,230

KALFA, T

RAC1 and RAC2 Guanosine Triphosphatases in Erythroid Function and Differentiation
K08 HL 08812602/11/08 - 11/30/12 $119,125 / $595,625

KALINYAK, K

Silent Cerebral Infarct Multi-Center Clinical Trial
U01 NS 04280409/30/03 - 06/30/10 $1,776 / $502,371
Stroke with Transfusions Changing to Hydroxyurea
U01 HL 07878704/01/06 - 06/30/11 $29,631 / $138,180

MARSH, R

Investigations into XIAP-Deficient X-linked Lymphoproliferative Disease
R03 AI 07979709/15/08 - 08/31/10 $50,000 / $100,000
The Pathogenesis of XILP Due to XIAP Deficiency
01/01/09 - 12/31/09 $50,000 / $50,000

MIZUKAWA, B

Pediatric Physician Scientist Program Award
K12 HD 00085007/01/08 - 06/30/10 $94,750 / $195,250

MORREALE, R

Training Program with Regulations of Cellular Growth and Differentiation
T32 CA 05926808/01/07 - 07/31/09 $38,976 / $75,972

MULLINS, E

Thrombin and Thrombin Targets in Allergen Airway Inflammation
07/01/08 - 06/30/10 $50,000 / $100,000

NAGARAJAN, R

Genetic Epidemiology of Osteosarcoma
U01 CA 12237105/01/07 - 04/30/11 $9,283 / $36,607

PALUMBO, J

Mechanisms Linking Metastasis to Tumor Procoagulant and Innate Immunity
R01 HL 08554507/20/06 - 06/30/11 $242,750 / $1,250,000

PERENTESIS, J

Children's Oncology Group New Publication Committee
U01 CA 09745209/01/06 - 07/31/09 $11,928 / $22,818
Children's Oncology Group Phase I Consortium (Per Patient)
U01 CA 09754208/01/07 - 07/31/09 $35,931 / $80,000
Children's Oncology Group Phase I Consortium
U01 CA 09754208/01/07 - 07/31/09 $21,888 / $43,138
Chairman's Award Children's Oncology Group
U10 CA 09854303/01/03 - 02/28/13 $23,913 / $208,335
Chairman's Award Children's Oncology Group(Per Patient)
U10 CA 09854303/01/08 - 02/28/13 $148,730 / $250,000
Cincinnati Center for Neurofibromatosis Research - Project 1
P50 NS 05753109/15/08 - 06/30/13 $304,308 / $1,521,540

PHILLIPS, C

Host Polymorphism and Acute Myelogenous Leukemia
07/01/08 - 06/30/09 $40,000 / $40,000
Pharmacogenetics in AML
01/15/09 - 01/14/10 $50,000 / $50,000

SHOOK, L

Cincinnati Sickle Cell Newborn Screening Network
H46 MC 00923306/01/08 - 05/31/11 $185,000 / $555,000

SMITH, F.

The Children's Oncology Group Chairs Grant
U10 CA 09854303/01/03 - 02/28/10 $111,275 / $313,395

SUMEGI, J

Search for Growth Inhibitory Genes in Ewing's Sarcoma
01/01/08 - 12/31/09 $30,031 / $90,351
Functional Identification of Genes Mutated in FHLH
R21 AI 07975907/15/08 - 06/30/10 $142,667 / $275,000
Revisiting the Candidate Regions for Familial Hemophagocytic Lymphohistiocytosis (FHLH)
01/01/09 - 12/31/09 $50,000 / $50,000

WAGNER, L.

Children's Oncology Group Phase I ADVL0414 Study Chair
U01 CA 09745208/01/07 - 01/31/09 $10,430 / $30,681

WELLS, S.

Role and Regulation of the Human DEK Proto-Oncogene
R01 CA 11631304/01/06 - 02/28/11 $172,353 / $887,500
HPV Replication and Transformation in FA Squamous Cell
03/01/09 - 02/28/11 $100,000 / $200,000
Current Year Direct$4,384,421
Industry Contracts

Kalinyak, K

$ 7,979

Geller, J

$ 11,696

Gruppo, R

$ 6,314
$ 11,519
$ 9,291

Harris, R

$ 5,582
$ 7,916

Mehta, P

$ 4,928

Smith, F

$ 53,686

Wagner, L

$ 9,324
Current Year Direct Receipts$142,754
Funded Collaborative Efforts

Bleesing, J

Cincinnati Multidisciplinary Clinical Research Center
Glass, David08/18/08 - 07/31/133 %

Filipovich, L

Gene Expression in Pediatric Arthritis - Project 4
Glass, David07/01/03 - 06/30/095 %

Kalinyak, K

Role of Placenta Growth Factor in Sickle ACS
Malik, Punam09/01/06 - 05/31/095 %

Perentesis, J

Neurobehavioral Late-Effects in Pediatric Brain Tumors
Ris, Douglas07/01/05 - 06/30/103 %

Perentesis, J

Promoting Treatment Adherence in Adolescent Leukemia
Drotar, Dennis09/28/07 - 07/31/123 %

Perentesis, J

NF Consortium Development Infrastructure
Schorry, Elizabeth07/01/08 - 06/30/105 %

Weiss, B

NF Consortium Development STOPn
Schorry, Elizabeth07/01/08 - 06/30/108.5 %
Total$ 4,527,175